FDA Device recall Z-2087-2015
RadiForce GX540, 5MP Monochrome LCD Monitor, Part Code No. 0FTD1826A5, 0FTD1826B5, 0FTD1826C5, UPC 690592034752
- FDA Device
- Class II
- terminated
- Published 2015-07-22
On 2015-07-22 the FDA classified a Class II recall of RadiForce GX540, 5MP Monochrome LCD Monitor, Part Code No. 0FTD1826A5, 0FTD1826B5, 0FTD1826C5, UPC 690592034752 by Eizo, citing EIZO is recalling the RadiForce LCD Monitors could display abnormally while connecting to particular graphics boards with DisplayPort.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2087-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-07 |
| Published | 2015-07-22 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Eizo |
| Distribution | US |
Product
RadiForce GX540, 5MP Monochrome LCD Monitor, Part Code No. 0FTD1826A5, 0FTD1826B5, 0FTD1826C5, UPC 690592034752. This product is intended to be used in displaying and viewing digital images including those of digital mammography for review and analysis by trained medical practitioners.
Reason
EIZO is recalling the RadiForce LCD Monitors could display abnormally while connecting to particular graphics boards with DisplayPort.
Identifiers
| upc | 690592034752 |
|---|---|
| code_info | 21839093 21840093 21841093 21845093 21849093 21850093 21851093 21855093 21856093 21861093 23641024 24340064…21839093 21840093 21841093 21845093 21849093 21850093 21851093 21855093 21856093 21861093 23641024 24340064 24343064 24347064 24358064 24359064 24368064 24728094 24736094 25103104 25104104 25127104 25129104 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2087-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.